Purple Biotech GAAP EPS of -$0.27 misses by $0.07

• Purple Biotech press release (NASDAQ:PPBT): Q3 GAAP EPS of -$0.27 misses by $0.07.
• As of September 30, 2022, the Company had a total amount of $35.7 million in cash, cash equivalent and short and long term deposits.